BullFrog AI Strengthens Balance Sheet, Eyes Commercial Growth

BullFrog AI has provided a business update, reporting a strengthened balance sheet that supports its ongoing execution and commercialization efforts. The company has secured runway into late 2027 and has entered into its first commercial agreement with a top-tier global pharmaceutical company. This anchors a growing pipeline of enterprise discussions. BullFrog AI is focused on ramping up commercial activity with pharmaceutical and biotechnology partners, indicating positive momentum and future growth prospects.